Aitheroscope analyzes eye fundus images to detect atherosclerosis before symptoms appear, with validation showing 5% false positives and 3% false negatives versus clinical standards. The Spanish startup has deployed across 18 clinical centers nationally and signed distribution agreements for Latin America, expanding access to early cardiovascular screening.
El Español
· May 04, 2026
· health
· 5 min de leitura
High
Apuração: Verificado
Spanish AI startup Aitheroscope uses retinal imaging to detect early atherosclerosis
The technology addresses significant underdiagnosis of atherosclerosis, particularly in women, where approximately 50% of heart attacks occur in patients previously classified as low-risk.
◉
Business
516 artigos relacionados
WTTC to establish permanent Madrid headquarters, hiring 45 internation…
LA RAZÓN · 80% correspondência
Pink Albatross seeks creditor protection as vegan ice cream startup ba…
El Español · 70% correspondência
Orange completes €4.25B acquisition to gain full control of MasOrange
Google News · 70% correspondência
Iberdrola celebra junta con récord de beneficios y ratifica a Azagra
Castellón Plaza · 70% correspondência
Google planea mayor inversión en IA para Search en 2025 pese a caída d…
Digital Trends Español · 70% correspondência
Cobertura Relacionada
El Ecosistema Startup · Aug 21
HR Startup Competition 2026: plazo hasta el 13 de septiembre para startups de recursos humanos
RRHHDigital abre la convocatoria de la HR Startup Competition 2026 para startups Early Stage en soluciones de gestión de…
Fichajes.com · Aug 21 Atlético Madrid cierra definitivamente la puerta a la salida de Julián ÁlvarezEl CEO del Atlético de Madrid, Miguel Ángel Gil Marín, confirmó que el club se quedará con Julián Álvarez pese a los int…
La Vanguardia · Aug 20 Altum Sequencing ultim a ronda de 5 millones para expandir su 'radar' contra el cáncerLa startup Altum Sequencing ultima una ronda de 5 millones de euros para expandir internacionalmente su tecnología de bi…
Funds Society · Aug 19 Multiplica: la AFP digital que revoluciona el sistema de pensiones en ChileMultiplica, una nueva AFP nativa digital respaldada por emprendedores chilenos, busca transformar el sistema de pensione…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Spanish AI startup Aitheroscope develops cardiovascular diagnostic technology with no direct geopolitical implications; represents European innovation in healthcare sector.
Escalation Risk
low
Confidence
HIGH
No significant power shifts. This is a commercial healthcare innovation with potential soft power benefits for Spain's tech ecosystem and EU digital health capabilities.
Lente Econômica
📈
Spanish AI startup Aitheroscope achieves 95% accuracy in early atherosclerosis detection via retinal imaging, addressing cardiovascular disease underdiagnosis and creating new primary care diagnostic market opportunities.
Market Signal
bullish
Confidence
HIGH
Healthcare/Medical Diagnostics
Artificial Intelligence/Software
Medical Devices
Primary Care Services
Insurance/Risk Assessment
Consumers gain access to non-invasive, early cardiovascular disease screening in primary care settings, potentially reducing preventable heart attacks and strokes through earlier intervention and treatment, while lowering out-of-pocket costs for advanced diagnostics.
Regulatory bodies (EMA, national health authorities) may need to establish AI diagnostic approval pathways; healthcare systems should consider integration into preventive screening protocols; insurance companies may adjust risk models and coverage based on early detection capabilities; data privacy regulations (GDPR) require careful implementation for retinal image processing.